Signal
Signal is Straker's new fortnightly investor newsletter. Its purpose is to provide consistent visibility into the developments shaping the business — strategic partnerships, product progress, and market positioning in the periods between our formal reporting. We'll keep each edition focused and substantive. This is the first; we look forward to keeping you informed.
Introducing arbitr
Issue #05The trust layer between AI and everything a company publishes.
Priced by the Word, Replaced by Trust
Issue #04David Sowerby on why translation's per-word pricing is ending, and the bigger, trust-priced business Straker is building in its place.
Why building your own AI models is hard, and why that matters.
Issue #03Why building your own AI models is harder than it looks, what Straker has learned doing it, and why that difficulty is the point for investors.
ASKA Pharmaceutical Holdings clears Japan’s new English-disclosure mandate with SwiftBridge AI
Issue #02How ASKA Pharmaceutical Holdings met Japan's new English-disclosure mandate on its first attempt with SwiftBridge AI, and the custom Straker model behind it.
Two hours that changed the room
Issue #01Signal is Straker's new fortnightly investor newsletter — consistent visibility into the developments shaping the business between our formal reporting. This is the first; we look forward to keeping you informed.